2025 Spring Symposium - Call for Presentation Abstracts

Step 1 of 4 - Call for Presentation Abstracts

Submit Date

General Information

HIMSS reserves the right to change your selected topic category, session format, session level as needed. If accepted, HIMSS may copy edit your session description and learning objectives for marketing materials.

Requirements:

- The proposal must not promote an organization, product and/or service. Avoid endorsements: do not explicitly endorse any products, solutions or services in your presentation. Your role as speaker is to inform, not to sell.
- It is recommended that proposals submitted by consultants or market suppliers include a provider/user participant as the primary speaker. For continuing education purposes, any form of commercialism or vendor bias in the proposal will not be accepted.
- When submitting a proposal, please ensure you provide comprehensive details and substantiating evidence that supports your content. This will not only strengthen your proposal but also facilitate the review scoring process. Detailed proposals with clear evidence enable reviewers to fully understand the scope, feasibility, and impact of your submission.
- Complete all components of the proposal (i.e. measurable outcomes, etc.).
- Be succinct in your text answers and avoid redundancy. Convey the critical points under each content section.
- Check for spelling errors.
- Include any URL links to charts/graphs/figures. Include references to existing works to build a case/rationale and discuss the broader generalizability of a case study. May also contain hyperlinks to open-source tools/websites.
- Identify and cite all sources and/or include all necessary acknowledgements.
- Obtain written permission from copyright holder to reproduce/include previously published figures, tables or text excerpts and acknowledge the original source in the figure caption or as a footnote.
- All necessary approvals/clearances are obtained before submission.
- Proposal should not contain plagiarism, invasion of privacy, violation of proprietary right or copyright, libelous or injurious matter.

There will be four educational tracks for this Symposium

Business

Guiding health leaders toward financial sustainability and operational excellence. Including clinically integrated supply chain, financial management and program management.

Care

Equipping caregivers with tools to keep patients and populations healthy. Including alternative care delivery models, patient experience/engagement and personalized medicine.

Health Equity

Technology that ensures everyone has a fair and equitable opportunity to attain their highest level of health.

Organizational Governance

Empowering health leaders to inspire change and lead strategically in areas of data governance, organizational management and sustainability.

Submitter Information

This should be the contact for abstract follow-up.

Name(Required)

First Last

Email(Required)

Organization Company(Required)

Phone Number (optional)

Presentation Details

Proposal Title(Required)

Please enter the proposal title below. Capitalize the first letter of each word except prepositions, conjunctions and articles. Do not use organization names in proposal titles.

Brief Summary Description: (150 word limit)(Required)

Provide a brief snapshot of the presentation including a brief rationale, findings and takehome message. If your proposal is selected, this brief summary description will appear in marketing materials, the website, etc. Do not list speaker names or organization names in this description.

Session Format: (select preferred option)(Required)

Case Study

Best Practice (traditional presentation)

Learning Burst

Tabletop

Panel Discussion

Topic Category: (select preferred option)(Required)

Business

Care

Health Equity

Organizational Governance

Learning Objectives

- HIMSS requires the use of Bloom’s Taxonomy. Please see learning objective instructions below and on website for more details. learning-objectives.pdf
- List 3 – 5 learning objectives, utilizing Bloom’s Taxonomy, to describe what attendees will gain by attending this session. At least three learning objectives are required.
- Each learning objective should be one-sentence, short and concise, without a period at the end of the sentence. All learning objectives need to start with active verbs and define an operational or behavioral objective. 50 words max for each learning objective, do not use periods.

Objective #1(Required)

Objective #2(Required)

Objective #3(Required)

Objective #4

Objective #5

Presentation Content Outline

When providing presentation content, please provide complete details and make certain to identify and cite data sources. Reviewers score proposals lower if not enough detail is provided. Please refer to the content requirements listed at the beginning of the content section.

Organization: (250 word limit)(Required)

Provide a brief description of the speaker(s) organization(s) including location, size, type of organization such as healthcare, hospital, consultant, government, market supplier, etc., and the role(s) this organization served in the topic of this proposed session.

Background: (500 word limit)(Required)

Provide an introduction/background of your topic including the problem statement, goals, objectives, etc.

Challenges: (500 word limit)(Required)

Describe any barriers or challenges and identify considerations or best practices the organization followed to mitigate these barriers.

Methods: (500 word limit)(Required)

Describe the study/project/process implementation used and provide a timeline. If applicable, include data collection methods and how it was measured.

Results / Findings: (500 word limit)(Required)

Identify any outcomes data (e.g. key performance indicators, pre-/post-implementation performance, or current performance data). If applicable, include how other variables not part of your study were accounted for and how factors (such as age, ethnicity, etc.) were adjusted pre-/post interventions so as to eliminate them as a co-founder.

Conclusions: (250 word limit)(Required)

Describe any conclusions such as lessons learned, outcomes, translation potentials to other sites, any clinical or organizational pearls, bottom line upfront.

Next Steps / Followup: (250 word limit)

If applicable, provide any next steps/follow-up that are important to this presentation. If none, enter NA.

Speaker Information

Before submitting a proposal or if submitting on behalf of another, all persons listed as speakers must agree to and have knowledge of being included in the proposal. It is recommended that proposals submitted by consultants or market suppliers include a provider/user participant as the primary speaker. For continuing education purposes, any form of commercialism or vendor bias in the proposal will not be accepted.

Speaker 1 Details

Same as Submitter

Speaker 1 is same as Submitter

Name(Required)

First Last

Organization Company(Required)

Role / Position(Required)

Email Address (optional)

LinkedIn Profile (optional)

Financial Relationship(s) Disclosure(Required)

I (or on Speaker's behalf) attest that clinical recommendations will be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).

Confirm

Conflict of Interest (COI)(Required)

I (or on Speaker's behalf) agree to disclose any unlabeled/unapproved uses of drugs or products referenced in my presentation/materials.

Confirm

Speaker 2

Add a 2nd Presenter

Speaker 2 Details

Same as Speaker 1

Organization is same as Speaker 1 organization

Name(Required)

First Last

Organization / Company(Required)

Role / Position(Required)

Email Address (optional)

LinkedIn Profile (optional)

Financial Relationship(s) Disclosure(Required)

I (or on Speaker's behalf) attest that clinical recommendations will be evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).

Confirm

Conflict of Interest (COI)(Required)

I (or on Speaker's behalf) agree to disclose any unlabeled/unapproved uses of drugs or products referenced in my presentation/materials.

Confirm